This page shows the latest Obamacare news and features for those working in and with pharma, biotech and healthcare.
In his latest move, the US president looks to once again take aim at Obamacare.
Aims to dismantle the programme. Healthcare looks set to dominate the US Presidential elections once again, after a White House call for the repeal of Obamacare sparked a swift response from ... Obamacare has extended medical insurance to more than 20
While attacking Obamacare was a staple of Republican campaigning ahead of Trump’s 2016 victory and afterwards, the approach seems to have backfired in a number of key seats, including Kansas’
Also, Obamacare customers whose incomes exceed those who qualify for subsidies will likely see sharp spikes in health insurance bills. ... Expect attorneys general in Democratic-controlled states to fight it tooth-and-nail, the same way Republican AsG
US President Donald Trump has launched a new assault on Obamacare, signing an executive order that will allow the sale of health insurance plans that are exempt from some of its ... Senior Democrats have accused the President of trying to undermine and
It’s even harder when you have no back-up plan. This is the undeniable lesson from the Obamacare debate that we’re witnessing. ... Before Obamacare became the law of the land, we knew that loss aversion in healthcare was a political hot potato.
More from news
Approximately 5 fully matching, plus 10 partially matching documents found.
Ten years ago, around the time the Affordable Care Act, ie, Obamacare, became law, Congress passed the Biologics Price Competition and Innovation (BPCI) Act, hoping it would do for biologics what ... When efforts by the Trump administration to repeal and
The US pharmaceutical industry has been told that Obamacare would be repealed, prices are too high and must come down and corporate tax rates will be reduced and modified to allow ... With the dysfunctional political system in the US it is hardly
as Obamacare) was partially responsible for this increase in desirability. ... It will be interesting to see what impact the Trump presidency has on this trend if Obamacare is dismantled.
In fact, it’s safe to say most C-suite drug executives would hardly shed a tear upon news of Obamacare’s swift demise. ... I think this goes all the way back to pushing Obamacare through Congress on a partisan vote.
bear on US drug prices and the possible revocation of Obamacare in part, if not in full. In addition, early press coverage suggests that there may be an introduction of a
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
as Obamacare) was partially responsible for this increase in desirability. ... It will be interesting to see what impact the Trump presidency has on this trend if Obamacare is dismantled. .
What seems to get US doctors I talk to most agitated is an aspect of Obamacare that gets relatively little attention outside the healthcare community: the “forced” conversion of medical practices
In the US, we have, and will continue to have, the shakedown from the implementation of the Affordable Care Act (aka Obamacare): the teething problems and the confusion, and gradually, so
What does the future hold for the US pharma industry? Everywhere you go in the States, you hear talk of the Affordable Care Act, also known as ObamaCare. In essence, the
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...